Latitude is significantly associated with the prevalence of multiple sclerosis: A meta-analysis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 82, Issue 10, 2011, Pages 1132-1141

  Simpson Jr , Steve ^a   Blizzard, Leigh ^a   Otahal, Petr ^a   Van Der Mei, Ingrid ^a   Taylor, Bruce ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; VITAMIN D;

ARTICLE; CORRELATION ANALYSIS; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE COURSE; ENVIRONMENTAL FACTOR; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GEOGRAPHIC DISTRIBUTION; HLA SYSTEM; HUMAN; LATITUDE; MULTIPLE SCLEROSIS; POPULATION RESEARCH; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX RATIO; STUDY DESIGN; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 80052610245     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2011.240432     Document Type: Article

References (37)

1. Kurtzke JF. General features on the prevalence of multiple sclerosis. J Indian Med Prof 1964;11:4896-901.
2. Kurtzke JF. A reassessment of the distribution of multiple sclerosis. Acta Neurol Scand 1975;51:137-57.
3. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci 2001;22:117-39. (Pubitemid 33771279)
4. Zivadinov R, Iona L, Monti-Bragadin L, et al. The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study. Neuroepidemiology 2003;22:65-74. (Pubitemid 36131978)
5. Alonso A, Hernan MA. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 2008;71:129-35.
6. Koch-Henriksen N, Sørensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010;9:520-32.
7. Hammond SR, McLeod JG, Millingen KS, et al. The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. Brain 1988;111:1-25.
8. Taylor B, Pearson JF, Clarke G, et al. MS prevalence in New Zealand, an ethnically and latitudinally diverse country. Mult Scler 2010;16:1422-31.
9. Kuroiwa Y, Shibasaki H, Ikeda M. Prevalence of multiple sclerosis and its north-to-south gradient in Japan. Neuroepidemiology 1983;2:62-9. (Pubitemid 14176783)
10. Vukusic S, Van Bockstael V, Gosselin S, et al. Regional variations in the prevalence of multiple sclerosis in French farmers. J Neurol Neurosurg Psychiatry 2007;78:707-9. (Pubitemid 46998840)
11. Kurtzke JF, Beebe GW, Norman JE Jr. Epidemiology of multiple sclerosis in US veterans: 1. Race, sex, and geographic distribution. Neurology 1979;29:1228-35. (Pubitemid 9231587)
12. Melcon MO, Gold L, Carra A, et al. Argentine Patagonia: prevalence and clinical features of multiple sclerosis. Mult Scler 2008;14:656-62. (Pubitemid 351954408)
13. Poppe AY, Wolfson C, Zhu B. Prevalence of multiple sclerosis in Canada: a systematic review. Can J Neurol Sci 2008;35:593-601.
14. Grønlie SA, Myrvoll E, Hansen G, et al. Multiple sclerosis in North Norway, and first appearance in an indigenous population. J Neurol 2000;247:129-33. (Pubitemid 30162528)
15. Rosati G. Descriptive epidemiology of multiple sclerosis in Europe in the 1980s: a critical overview. Ann Neurol 1994;36(Suppl 2):S164-74. (Pubitemid 24370938)
16. Van der Mei IA, Ponsonby AL, Dwyer T, et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ 2003;327:316.
17. Tremlett H, Van der Mei IA, Pittas F, et al. Monthly ambient sunlight, infections and relapse rates in multiple sclerosis. Neuroepidemiology 2008;31:271-9.
18. Simpson S Jr, Taylor B, Blizzard L, et al. Higher 25-hydroxyvitamin D is associated with lower relapse risk in MS. Ann Neurol 2010;68:193-203.
19. Middleton D, Menchaca L, Rood H, et al. Tissue antigens 2003;61:403-07. New Allele Frequency Database. http://www.allelefrequencies.net.
20. Breslow NE, Day NE. Statistical Methods in Cancer Research: Volume II - The Design and Analysis of Cohort Studies. Lyon: International Agency for Research on Cancer, 1987.
21. Population-Division: United States Census Bureau, 2010. International Data Base. http://www.census.gov/ipc/www/idb/index.php.
22. Kleinbaum DG, Kupper LL, Muller KE, et al. Multiple regression analysis: general considerations. In: Kugushev A, ed. Applied Regression Analysis and Multivariable Methods. 3rd edn. South Melbourne: Brooks/Cole Publishing Company, 1998:111-35.
23. Schmidt H, Williamson D, Ashley-Koch A. HLA-DR15 haplotype and multiple sclerosis: a HuGE review. Am J Epidemiol 2007;165:1097-109. (Pubitemid 47233710)
24. Einarsdottir E, Egerbladh I, Beckman L, et al. The genetic population structure of northern Sweden and its implications for mapping genetic diseases. Hereditas 2007;144:171-80. (Pubitemid 350142210)
25. De Graaf AS. Multiple sclerosis in northern Norway. Eur Neurol 1974;11:281-95.
26. Grønning M, Mellgren SI. Multiple sclerosis in the two northernmost counties of Norway. Acta Neurol Scand 1985;72:321-7. (Pubitemid 16237680)
27. Kampman MT, Brustad M. Vitamin D. A candidate for the environmental effect in multiple sclerosis - observations from Norway. Neuroepidemiology 2008;30:140-6. (Pubitemid 351667793)
28. Freisling H, Fahey MT, Moskal A, et al. Region-specific nutrient intake patterns exhibit a geographical gradient within and between European countries. J Nutr 2010;140:1280-6.
29. Brustad M, Alsaker E, Engelsen O, et al. Vitamin D status of middle-aged women at 65-71 degrees N in relation to dietary intake and exposure to ultraviolet radiation. Public Health Nutr 2004;7:327-35. (Pubitemid 38419619)
30. Burgaz A, Akesson A, Oster A, et al. Associations of diet, supplement use, and ultraviolet B radiation exposure with vitamin D status in Swedish women during winter. Am J Clin Nutr 2007;86:1399-404. (Pubitemid 350126244)
31. Brustad M, Sandanger T, Aksnes L, et al. Vitamin D status in a rural population of northern Norway with high fish liver consumption. Public Health Nutr 2004;7:783-9. (Pubitemid 39159047)
32. Elmadfa I, Weichselbaum E. Energy and Nutrient Intake in the European Union. European Nutrition And Health Report 2004 (Forum of Nutrition/Bibliotheca Nutritio Et Dieta). Vienna: Karger, 2005.
33. Brustad M, Edvardsen K, Wilsgaard T, et al. Seasonality of UV-radiation and vitamin D status at 69 degrees north. Photochemical Photobiol Sci 2007;6:903-8. Official journal of the European Photochemistry Association and the European Society for Photobiology. (Pubitemid 47197876)
34. Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006;296:2832-8. (Pubitemid 44969183)
35. Munger KL, Zhang SM, O'Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004;63:939. (Pubitemid 39297673)
36. Handel AE, Handunnetthi L, Giovannoni G, et al. Genetic and environmental factors and the distribution of multiple sclerosis in Europe. Eur J Neurol 2010;17:1210-14.
37. Orton SM, Herrera BM, Yee IM, et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006;5:932-6. (Pubitemid 44556546)